Viewing Study NCT04656106


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2026-04-19 @ 9:12 AM
Study NCT ID: NCT04656106
Status: COMPLETED
Last Update Posted: 2021-09-28
First Post: 2020-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea
Sponsor:
Organization:

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: